Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com Prev Post Binding Commitments Received for A$1.0 Million under Convertible Note Placement April 28, 2025 Next Post IBM pledges $150 billion to boost U.S. tech growth, computer manufacturing April 29, 2025 Related Posts Stallion Uranium Announces Update to Previously Announced Technology Licensing Agreement August 1, 2025 Skyharbour Resources August 1, 2025 Silver Crown Announces Amendment August 1, 2025
Stallion Uranium Announces Update to Previously Announced Technology Licensing Agreement August 1, 2025